正大企业国际发布年度业绩 股东应占溢利3205.5万美元 同比增长187.03%

Core Viewpoint - Charoen Pokphand International (03839) reported a significant increase in revenue and profit for the fiscal year ending December 31, 2025, primarily driven by strong growth in its biotechnology business [1] Financial Performance - The company achieved revenue of approximately $536 million, representing a year-on-year growth of 74.14% [1] - Shareholders' profit attributable to the company was $32.055 million, marking a year-on-year increase of 187.03% [1] - Basic earnings per share were reported at 12.65 cents [1]